Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy

    January 2026 in “ Clinics and Practice ”
    Enrico Matteini, Fabio Artosi, Giacomo Caldarola … Jan Maschke
    Studysummary In this retrospective case series, baricitinib showed effectiveness in treating alopecia areata, with some potential benefits for psoriasis, but it may not be suitable for managing psoriatic arthritis in patients with these coexisting conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Effect of Baricitinib in Patients with Alopecia Areata: Usefulness of Trichoscopic Evaluation Journal of the European Academy of Dermatology and Venereology · 2023
    2. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023
    3. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata Dermatology and therapy · 2023
    4. Application of Baricitinib in Dermatology Journal of inflammation research · 2022
    5. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside Frontiers in immunology · 2020
    6. Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis During Treatment with Tofacitinib: A Case Report Case Reports in Dermatology · 2020
    7. Alopecia Areata Profiling Shows TH1, TH2, and IL-23 Cytokine Activation Without Parallel TH17/TH22 Skewing ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology · 2015